Pioneering access to complex generic productsÂ
Drug Discovery World
AUGUST 22, 2023
In September 2021, the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) announced the initiation of a pilot programme 1 to provide parallel scientific advice to pharma companies applying for marketing authorisation for generic versions of hybrid products and complex generic drug products.
52 
Let's personalize your content